Skip to content

Study on Analgesia and Neural Network Mechanism of Acupuncture and Drug Combined Anesthesia in Minimally Invasive Surgery of Lung Cancer

Study on Analgesia and Neural Network Mechanism of Acupuncture and Drug Combined Anesthesia in Minimally Invasive Surgery of Lung Cancer

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100046940
Enrollment
Unknown
Registered
2021-05-31
Start date
2021-06-01
Completion date
Unknown
Last updated
2022-01-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

lung cancer

Interventions

Sponsors

Beijing Cancer Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Aged >18 and < 80 years; 2. Perform lung surgery for the first time; 3. There has been no combined acupuncture and medicine anesthesia in the past.

Exclusion criteria

Exclusion criteria: 1. Unwilling to perform electrical stimulation on acupoints; 2. Patients with skin infections in the acupoints; 3. Patients with upper or lower limb nerve injury; 4. Patients who have participated in other clinical trials within the past four weeks; 5. Patients who cannot cooperate with the completion of the research plan, including those with language difficulties, infectious diseases or conscious disabilities; 6. Severe liver, kidney, brain, and lung diseases immediately before the operation; 7. Body mass index =30 kg/m^2; 8. There is a history of drug abuse.

Design outcomes

Primary

MeasureTime frame
Intraoperative and postoperative analgesic drug dosage;Visual analogue scale (VAS) for postoperative pain;

Countries

China

Contacts

Public ContactChen Jiheng

Beijing Cancer Hospital

2238165366@qq.com+86 10 88196553

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026